Deepu Gupta’s Post

Register Now for MicroembART 1.0 Save the date : 08th-09th June 2024 Round Table Meeting : KPIs in Embryo Culture : Navigating Patient Outcomes and Laboratory Efficiency

🧑🔬 Dr. Marco Quarta, CEO of Rubedo Life Sciences, #portfolio IAG, was interviewed by Nina Ruge at Forever Healthy's Rejuvenation Startup Summit, where he discussed their cutting-edge strategy in the fight against senescent cells.   🔬 What Stood Out: • Rubedo is leveraging its Alembic platform, combining AI and genomics to precisely target senescent cells associated with various diseases, enabling the creation of highly selective treatments. • Their first drug, RLS-1496, is set to enter clinical trials this year, focusing on treating chronic inflammatory skin conditions. This is a major step toward broader therapies targeting other tissues, like the lungs and liver. • Rubedo has also partnered with Beiersdorf to develop a cosmetic cream aimed at rejuvenating aging skin, offering a practical anti-aging solution beyond medical treatments.   👀 Check-out the interview   #Longevity #Biotech #AI #Genomics #AntiAging #HealthTech #Innovation #ClinicalTrials #SkinCare #Rejuvenation #HealthyAging

Exciting news from QIAGEN! Introducing the TissueLyser III and RNeasy PowerMax Soil Pro Kit, empowering researchers with enhanced sample processing and RNA isolation capabilities. These innovations promise efficient handling of challenging materials like bone, tissue, and soil, ensuring higher accuracy and efficiency in diverse research fields. https://lnkd.in/eWQpu7p8 📰 Follow Practical Patient Care to receive the latest healthcare news daily that is important to you and to subscribe to our weekly newsletter #practicalpatientcare #QIAGEN #SampleProcessing #RNAIsolation"

Watch an #agingshort #video of this #review selected as the #cover for Volume 16, Issue 15: “Types of cell death and their relations to host immunological pathways." https://lnkd.in/eWehGteH #aging #apoptosis #autophagy #cellscience #openaccess #research #publishing #meded

#callforreading #recommendations in Methods and Protocols MDPI Title: Method of Microglial DNA-RNA Purification from a Single Brain of an Adult Mouse Authors: Md Obayed Raihan, Brett A. McGregor, Nathan A. Velaris, Afrina Brishti, Junguk Hur and James E. Porter from University of North Dakota School of Medicine and Health Sciences Read and Download for #free at: https://lnkd.in/eeuyHJE4 #methods #protocols #separation #rna #dna #extraction #immune #cells #therapeutic #target

Dive into our latest blog post to review our cutting-edge enhancements to the GO Pathology Workbench. Review: 👉 The core principles and complexities of germline analysis to understand its critical role in precision medicine 👉 How the platform leverages the ACMG/AMP classification system to simplify variant analysis and review processes, ensuring accuracy and reliability 👉 How the platform's versatility, compatibility with various assays and formats, centralized database for variant curation, and customizable reporting capabilities combine to offer a holistic solution for both somatic and germline analysis needs. Read more: https://ow.ly/Pzhb50RqS8u #somatic #germline #tertiaryanalysis #precisionmedicine

Mastering Pathological Staining: Simple Solutions for Accurate Diagnoses and Reliable Research. #KFBIO #PathologyTips #Diagnostics #ResearchIntegrity

In the journey of drug discovery, selecting the right model is not just a step—it's a leap toward success. Our CEO, Jos Joore, and Director of Biology Discovery, Lenie van den Broek, delve into the limitations of traditional disease models in this video. Watch and learn how MIMETAS' physiologically-relevant 3D disease models can transform your drug discovery process by enabling more accurate clinical predictions. 🔍 Discover how our offerings can accelerate your projects. Watch now and explore our offerings: https://lnkd.in/evue8i28 #DrugDiscovery #ClinicalAccuracy #PredictiveModels

Unravel the mysteries of your genetic blueprint with JNU Hospital's cutting-edge DNA technology. From personalized medicine to advanced diagnostics, discover how your DNA holds the key to optimized healthcare. #DNADay

🧱 Builders: Keith Gottesdiener - President & CEO @ Prime Medicine, Inc. Dive into the future of gene editing with our latest episode featuring Keith Gottesdiener, CEO of Prime Medicine, Inc. Discover how Prime Editing is setting the stage for groundbreaking treatments and the potential to cure genetic diseases. Keith shares insights on the journey from a visionary Nature paper to leading the charge in gene editing, the challenges of bringing a novel technology to market, and Prime Medicine's ambitious plans for the future. This episode is a must-listen for anyone interested in the cutting edge of medical innovation and the transformative potential of gene editing. Tune in to hear how Prime Medicine is shaping the future of healthcare, one gene at a time. Watch it here: https://buff.ly/3IdqkSY #GeneEditing #PrimeMedicine #HealthcareInnovation